Efficacy and safety of inotuzumab ozogamicin and its combination therapies in acute lymphoblastic leukemia: a systematic review and meta-analysis.
Saved in:
| Title: | Efficacy and safety of inotuzumab ozogamicin and its combination therapies in acute lymphoblastic leukemia: a systematic review and meta-analysis. |
|---|---|
| Authors: | Lao C; Department of Hematopathology, Peking University Shenzhen Hospital, Shenzhen, China., Wen J; Nursing Department, Shenshan Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Shanwei, China., Wen Y; Department of Hematopathology, Peking University Shenzhen Hospital, Shenzhen, China. |
| Source: | Frontiers in oncology [Front Oncol] 2025 Nov 04; Vol. 15, pp. 1613777. Date of Electronic Publication: 2025 Nov 04 (Print Publication: 2025). |
| Publication Type: | Journal Article; Systematic Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41262905 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy and safety of inotuzumab ozogamicin and its combination therapies in acute lymphoblastic leukemia: a systematic review and meta-analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lao+C%22">Lao C</searchLink>; Department of Hematopathology, Peking University Shenzhen Hospital, Shenzhen, China.<br /><searchLink fieldCode="AU" term="%22Wen+J%22">Wen J</searchLink>; Nursing Department, Shenshan Medical Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Shanwei, China.<br /><searchLink fieldCode="AU" term="%22Wen+Y%22">Wen Y</searchLink>; Department of Hematopathology, Peking University Shenzhen Hospital, Shenzhen, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Nov 04; Vol. 15, pp. 1613777. <i>Date of Electronic Publication: </i>2025 Nov 04 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Systematic Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41262905 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2025.1613777 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1613777 Titles: – TitleFull: Efficacy and safety of inotuzumab ozogamicin and its combination therapies in acute lymphoblastic leukemia: a systematic review and meta-analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lao C – PersonEntity: Name: NameFull: Wen J – PersonEntity: Name: NameFull: Wen Y IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 11 Text: 2025 Nov 04 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 15 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
